Advances in research on malignant transformation of endometriosis-associated ovarian cancer

被引:0
作者
Chen, Fang [1 ]
Zhu, Mengying [2 ]
Li, Wenjuan [1 ]
机构
[1] Peoples Hosp Liaoning Prov, Dept Gynecol, Shenyang, Peoples R China
[2] Liaoning Univ Tradit Chinese Med, Shenyang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
endometriosis; endometriosis-associated ovarian carcinoma; malignant transformation; ovarian clear cell carcinoma; ovarian endometrioid carcinoma; CLEAR-CELL CARCINOMA; EPITHELIAL OVARIAN; FALLOPIAN-TUBE; DOSE-DENSE; CHEMOTHERAPY; PACLITAXEL; MUTATIONS; METHYLATION; MECHANISMS; EXPRESSION;
D O I
10.3389/fonc.2024.1475231
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometriosis (EMs) is a prevalent chronic gynecological condition that depends on estrogen, marked by the presence of active endometrial tissue (glands and stroma) outside the uterus. Although pathologically benign, it exhibits biological behaviors such as invasion and metastasis akin to malignant tumors. Endometriosis-associated ovarian carcinoma (EAOC), arising from malignant transformation of EMs, poses significant clinical challenges. However, the mechanisms underlying EAOC pathogenesis remain incompletely understood, with a lack of reliable biomarkers for early diagnosis and personalized treatment strategies. Considering the significant number of EMs patients and the extended period during which malignant transformation can occur, EAOC deserves significant attention. Current research both domestically and internationally indicates that the pathogenesis of EAOC is complex, involving genetic mutations, immune microenvironment, oxidative stress, epigenetic changes, and related areas. This review summarizes the mechanisms underlying the development of EAOC.
引用
收藏
页数:9
相关论文
共 82 条
  • [31] Electron Donor-Acceptor Complex Enabled Cyclization/Sulfonylation Cascade of N-Heterocycles with Thianthrenium Salts
    He, Zhengjun
    Li, Zhi
    Lai, Shuo
    Li, Hongji
    [J]. ORGANIC LETTERS, 2024, 26 (31) : 6652 - 6657
  • [32] Tissue and circulating microRNA influence reproductive function in endometrial disease
    Hull, M. Louise
    Nisenblat, Victoria
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2013, 27 (05) : 515 - 529
  • [33] Oxidative Stress and Human Ovarian Response-From Somatic Ovarian Cells to Oocytes Damage: A Clinical Comprehensive Narrative Review
    Immediata, Valentina
    Ronchetti, Camilla
    Spadaro, Daria
    Cirillo, Federico
    Levi-Setti, Paolo Emanuele
    [J]. ANTIOXIDANTS, 2022, 11 (07)
  • [34] Regulation of Electroneutral NaCl Absorption by the Small Intestine
    Kato, Akira
    Romero, Michael F.
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, VOL 73, 2011, 73 : 261 - 281
  • [35] PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
    Kitamura, Sachiko
    Yamaguchi, Ken
    Murakami, Ryusuke
    Furutake, Yoko
    Higasa, Koichiro
    Abiko, Kaoru
    Hamanishi, Junzo
    Baba, Tsukasa
    Matsumura, Noriomi
    Mandai, Masaki
    [J]. CANCER SCIENCE, 2021, 112 (11) : 4627 - 4640
  • [36] Clinicopathological characteristics, molecular features and novel diagnostic strategies for the detection of malignant transformation of endometriosis (Review)
    Kobayashi, Hiroshi
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (06)
  • [37] Molecular signatures of ovarian diseases: Insights from network medicine perspective
    Kori, Medi
    Gov, Esra
    Arga, Kazim Yalcin
    [J]. SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE, 2016, 62 (04) : 266 - 282
  • [38] Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
    Kuo, Kuan-Ting
    Mao, Tsui-Lien
    Jones, Sian
    Veras, Emanuela
    Ayhan, Ayse
    Wang, Tian-Li
    Glas, Ruth
    Slamon, Dennis
    Velculescu, Victor E.
    Kuman, Robert J.
    Shih, Ie-Ming
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (05) : 1597 - 1601
  • [39] ERK1/2-RSK2 Signaling in Regulation of ERα-Mediated Responses
    Lannigan, Deborah A.
    [J]. ENDOCRINOLOGY, 2022, 163 (09)
  • [40] Ledermann JA, 2020, LANCET ONCOL, V21, P710, DOI 10.1016/S1470-2045(20)30061-9